Gene: PSME4
Official Full Name: proteasome activator subunit 4provided by HGNC
Gene Summary: Predicted to enable lysine-acetylated histone binding activity; peptidase activator activity; and proteasome binding activity. Predicted to be involved in DNA repair; proteasomal ubiquitin-independent protein catabolic process; and sperm DNA condensation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29680 | PSME4 Knockout cell line (HeLa) | Human | PSME4 | 1:3~1:6 | Negative | Online Inquiry |
KO29681 | PSME4 Knockout cell line (HCT 116) | Human | PSME4 | 1:2~1:4 | Negative | Online Inquiry |
KO29682 | PSME4 Knockout cell line (HEK293) | Human | PSME4 | 1:3~1:6 | Negative | Online Inquiry |
KO29683 | PSME4 Knockout cell line (A549) | Human | PSME4 | 1:3~1:4 | Negative | Online Inquiry |
PSME4 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the expression of the PSME4 gene, which encodes for a subunit of the proteasome complex, an essential component of the ubiquitin-proteasome system responsible for protein degradation and regulation. These knockout cell lines serve as a powerful tool for researchers aiming to study the biological functions of PSME4 and its role in cellular processes such as protein homeostasis, cell cycle regulation, and apoptosis.
The primary mechanism by which these cell lines operate is through the complete ablation of PSME4 expression, leading to observable alterations in proteasomal activity. This can result in an accumulation of misfolded proteins and altered signaling pathways that researchers can study to understand disease mechanisms, including cancer and neurodegenerative disorders where proteasome dysfunction is implicated. The PSME4 Gene Knockout Cell Lines offer a clear advantage in elucidating the downstream effects of the loss of PSME4, providing insights into therapeutic targets for a variety of conditions.
In research and clinical settings, these cell lines are invaluable for drug discovery and development, as they facilitate the evaluation of therapeutic compounds that might restore proteostasis or target aberrant signaling due to PSME4 deficiency. Compared to conventional knockout methods, these specifically engineered cell lines offer consistency and reproducibility in results, thereby enhancing the reliability of experimental outcomes.
The significance of PSME4 Gene Knockout Cell Lines extends beyond basic research; they provide the ability to model specific diseases, paving the way for innovative treatment strategies. For researchers and clinicians alike, these cell lines are a vital resource that accelerates progress in understanding complex biological processes and developing targeted therapies.
Our company boasts a strong commitment to advancing scientific research through high-quality genetic models, including PSME4 Gene Knockout Cell Lines. Our expertise in genetic engineering ensures that our products meet the highest standards, offering researchers the reliability they need to make meaningful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.